TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31518550

Group type: EXPERIMENTAL
Intervention: Normal placental growth factor (>100 pg/mL)
Number of subjects: 753

Group type: COMPARATOR
Intervention: Placental growth factor ≤100 pg/mL
Number of subjects: 753

Group type: EXPERIMENTAL
Intervention: Placental growth factor <12 pg/mL
Number of subjects: 753

Group type: EXPERIMENTAL
Intervention: Placental growth factor 12-100 pg/mL
Number of subjects: 753
Study: 29642710

Group type: EXPERIMENTAL
Intervention: Simulation-based communication training
Number of subjects: 45

Group type: COMPARATOR
Intervention: Didactic session
Number of subjects: 45
Study: 27350268

Group type: EXPERIMENTAL
Intervention: Continuous wound infiltration (CWI) with 0.2% ropivacaine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Single intercostal nerve block (ICNB) with 10 ml of 0.75% ropivacaine
Number of subjects: 48
Study: 24960095

Group type: EXPERIMENTAL
Intervention: Deep oscillation treatment applied for at least one week following the operation.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no deep oscillation treatment).
Number of subjects: 40
Study: 22061048

Group type: EXPERIMENTAL
Intervention: Perturbation training
Number of subjects: 21
Study: 19819439

Group type: EXPERIMENTAL
Intervention: Harmonic scalpel
Number of subjects: 160

Group type: COMPARATOR
Intervention: Electrosurgery
Number of subjects: 160
Study: 18812670

Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Amiodarone plus Irbesartan
Number of subjects: 91
Study: 14987329

Group type: EXPERIMENTAL
Intervention: 3 x 60 mg orlistat
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3 x 120 mg orlistat
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 11433843

Group type: EXPERIMENTAL
Intervention: Functional endoscopic nasosinus surgery (FENS)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Functional endoscopic sinus surgery (FESS)
Number of subjects: 64
Study: 9720728

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy with autologous stem cell transplantation (ASCT)
Number of subjects: 171
Study: 7731900

Group type: EXPERIMENTAL
Intervention: T and B lymphocytes
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: B lymphocytes
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: T cells
Number of subjects: 17
Study: 2736420

Group type: EXPERIMENTAL
Intervention: 0.125 mg/kg etomidate (group I; n = 6)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg etomidate (group II; n = 6)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg etomidate (group III; n = 6)
Number of subjects: 18
Study: 30907769

Group type: EXPERIMENTAL
Intervention: Problem-solving training program (eight sessions over 4 weeks)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 72
Study: 31162756

Group type: EXPERIMENTAL
Intervention: Videoconference-delivered mobile health pain coping skills training (mPCST)
Number of subjects: 178

Group type: COMPARATOR
Intervention: In-person pain coping skills training (PCST-traditional)
Number of subjects: 178
Study: 28397524

Group type: EXPERIMENTAL
Intervention: Nitrox28
Number of subjects: 108

Group type: COMPARATOR
Intervention: Air
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Female divers
Number of subjects: 108
Study: 24901734

Group type: EXPERIMENTAL
Intervention: Ibrutinib 420 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bendamustine and Rituximab (BR)
Number of subjects: 0
Study: 23410553

Group type: EXPERIMENTAL
Intervention: Gait parameters (forward displacement category: speed, stride length, hip flexion, knee flexion)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Gait parameters (frontal category: thorax obliquity, knee adductor moments)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: WOMAC Index for pain and function assessment
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Hip-knee-ankle angle on full-limb radiography for knee joint deformity assessment
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Full body gait analysis using motion analysis system and force plates
Number of subjects: 90
Study: 22177541

Group type: EXPERIMENTAL
Intervention: Pre-operative fluid loading with 25 ml/kg of Ringer's solution in the six hours before surgery
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control group with no pre-operative fluid loading
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Pre-operative fluid loading
Number of subjects: 111
Study: 19818722

Group type: EXPERIMENTAL
Intervention: 11-valent pneumococcal protein D conjugate vaccine
Number of subjects: 0
Study: 16513447

Group type: EXPERIMENTAL
Intervention: Telithromycin 800 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Montelukast 10 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Combination of telithromycin and montelukast
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 15568664

Group type: EXPERIMENTAL
Intervention: Complex drug and laser therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Drug therapy
Number of subjects: 100
Study: 10657288

Group type: EXPERIMENTAL
Intervention: Carbamazepine (200 mg)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 9381027

Group type: EXPERIMENTAL
Intervention: Cognex (donepezil) treatment, specific dosage and duration not mentioned
Number of subjects: 0
Study: 8317820

Group type: EXPERIMENTAL
Intervention: Inhaled PGE2 (100 micrograms)
Number of subjects: 8
Study: 3519736

Group type: EXPERIMENTAL
Intervention: Special Intervention (SI) group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual Care (UC) group
Number of subjects: 0
Study: 29536252

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5% administered for local wound infiltration
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline solution (control group)
Number of subjects: 60
Study: 27494527

Group type: EXPERIMENTAL
Intervention: Elevated fasting blood glucose (FBG)
Number of subjects: 2862

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 2862

Group type: EXPERIMENTAL
Intervention: Higher NIHSS
Number of subjects: 2862

Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 2862

Group type: EXPERIMENTAL
Intervention: Elevated fasting blood glucose (FBG) in patients without pre-diagnosed diabetes
Number of subjects: 2862

Group type: COMPARATOR
Intervention: Elevated fasting blood glucose (FBG) in patients with pre-diagnosed diabetes
Number of subjects: 2862
Study: 23898989

Group type: EXPERIMENTAL
Intervention: RQ (n = 17)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: VT (n = 15)
Number of subjects: 32

Group type: COMPARATOR
Intervention: RQ and VT
Number of subjects: 32
Study: 22791991

Group type: EXPERIMENTAL
Intervention: Roflumilast 500 μg once daily
Number of subjects: 967

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 967
Study: 21120297

Group type: EXPERIMENTAL
Intervention: Local Anesthetic with Vasoconstrictor (LAVA; 2% mepivacaine with adrenaline 1:100,000)
Number of subjects: 37

Group type: COMPARATOR
Intervention: No Local Anesthetic
Number of subjects: 37
Study: 18559704

Group type: EXPERIMENTAL
Intervention: SFJ ligation with polytetrafluoroethylene patch
Number of subjects: 292

Group type: COMPARATOR
Intervention: SFJ ligation surgery
Number of subjects: 292
Study: 15532135

Group type: EXPERIMENTAL
Intervention: Alteplase
Number of subjects: 624
Study: 11744467

Group type: EXPERIMENTAL
Intervention: Saw palmetto
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 9503259

Group type: EXPERIMENTAL
Intervention: Clozapine treatment (24 +/- 15 months prior to study)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Clozapine treatment (6 weeks)
Number of subjects: 40
Study: 8281590

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 23

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 23
Study: 3732427

Group type: EXPERIMENTAL
Intervention: 0.2 mg of fenoterol in powder form
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0.2 mg of fenoterol in MDI form
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo powder
Number of subjects: 20
Study: 31805869

Group type: EXPERIMENTAL
Intervention: Personalizing the address, enclosing a $2 cash incentive with the initial questionnaire mailing, and repeated follow-up mailings
Number of subjects: 4080

Group type: COMPARATOR
Intervention: Survey incentive, survey length, number of follow-up waves, field study incentive, age, or sex
Number of subjects: 4080
Study: 28188479

Group type: EXPERIMENTAL
Intervention: Medium dose UVB irradiation (0.70 minimal erythema dose)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: High dose UVB irradiation (1.75 minimal erythema dose)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Low dose UVB irradiation (0.28 minimal erythema dose)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Normal weight subjects receiving medium dose UVB irradiation
Number of subjects: 6

Group type: COMPARATOR
Intervention: Obese control group (no treatment)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Normal weight control group (no treatment)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Comparison of obese patients to normal weight controls irradiated with equal UVB doses
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 1,25D levels
Number of subjects: 6
Study: 26741127

Group type: EXPERIMENTAL
Intervention: Doxazosin 4 mg daily
Number of subjects: 15
Study: 25136048

Group type: EXPERIMENTAL
Intervention: Vitamin A Supplementation (VAS) 100000 IU for 6-11 months, 200000 IU for 12-23 months
Number of subjects: 7587

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7587
Study: 22585090

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (1100 IU/d)
Number of subjects: 1179

Group type: EXPERIMENTAL
Intervention: Increase in vitamin D intake
Number of subjects: 1179

Group type: EXPERIMENTAL
Intervention: Baseline serum 25(OH)D level
Number of subjects: 1179

Group type: EXPERIMENTAL
Intervention: Baseline blood collection season
Number of subjects: 1179

Group type: EXPERIMENTAL
Intervention: Baseline serum calcium level
Number of subjects: 1179

Group type: EXPERIMENTAL
Intervention: Baseline body mass index
Number of subjects: 1179
Study: 19594042

Group type: EXPERIMENTAL
Intervention: Knife needle treatment for 3 weeks
Number of subjects: 69

Group type: COMPARATOR
Intervention: Electroacupuncture treatment for 3 weeks
Number of subjects: 69
Study: 17469105

Group type: EXPERIMENTAL
Intervention: Rituximab treatment
Number of subjects: 15
Study: 15333303

Group type: EXPERIMENTAL
Intervention: Environmental intervention to increase availability of lower-fat foods and student-based promotions
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group with no intervention
Number of subjects: 20
Study: 11424822

Group type: EXPERIMENTAL
Intervention: ECG-guided technique (group A)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional method (group B)
Number of subjects: 44
Study: 9060535

Group type: EXPERIMENTAL
Intervention: Replens (polycarbophil-based vaginal moisturizer)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo lubricating product
Number of subjects: 45
Study: 8351679

Group type: EXPERIMENTAL
Intervention: Dimethicone (Gel de Polysilane Midy) with ethyl biscoumacetate (300 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Ethyl biscoumacetate (300 mg) alone
Number of subjects: 6
Study: 3529921

Group type: EXPERIMENTAL
Intervention: estramustine phosphate (EMP)
Number of subjects: 236

Group type: COMPARATOR
Intervention: diethylstilbestrol (DES)
Number of subjects: 236
Study: 29038286

Group type: EXPERIMENTAL
Intervention: Intra-aortic MSCs (AC607; n=67)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo (n=68)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Intra-aortic MSCs (AC607)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study: 27768503

Group type: EXPERIMENTAL
Intervention: Alcohol consumption (0.88g ethanol/kg body weight)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Iso-caloric placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 8
Study: 26437311

Group type: EXPERIMENTAL
Intervention: 10 session cognitive behavioral therapy (IPaViT‐CBT) group intervention
Number of subjects: 14

Group type: COMPARATOR
Intervention: treatment as usual
Number of subjects: 14
Study: 24176784

Group type: EXPERIMENTAL
Intervention: Yoga-based Psychotherapy Group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MindBody Course
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yoga and Stress Management Intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Yoga
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapeutic Yoga Program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Yoga and Life Skills Eating Disorder Prevention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Yoga and Physical Education
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yoga and Wellness Education
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Kundalini Mantra and Meditation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Kundalini Yoga Therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yoga Programs for Smoking Cessation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pranayam Practice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tailored Yoga Program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yoga-based Intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yoga-based Interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yoga Therapy Adapted for Older Veterans
Number of subjects: 0

Group type: COMPARATOR
Intervention: Yoga for Women With Major Depressive Disorder
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yoga Telehealth Program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yoga Practice Frequency
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medical Yoga
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Classroom-based Yoga Intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yoga Therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yoga and Stress Management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Whole-systems Ayurveda and Yoga Therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yoga for Smoking Cessation Treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mindfulness Program for Female Inmates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yoga After Stroke
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tele-Yoga
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ashtanga Yoga-based Curriculum
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yoga for Individuals With Chronic Stroke
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standardization of Yoga Interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Africa Yoga Project Teachers
Number of subjects: 0
Study: 21484739

Group type: EXPERIMENTAL
Intervention: Ropivacaine injections (19 patients)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Saline injections (14 patients)
Number of subjects: 33
Study: 18575447

Group type: EXPERIMENTAL
Intervention: Comprehensive prophylaxis for DVT including Aspirin, fibrinolytic enzyme, passive and active circumduction of the foot and ankle, CPM management
Number of subjects: 157

Group type: COMPARATOR
Intervention: No thromboproxylaxis (Control group)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Comprehensive prophylaxis for DVT
Number of subjects: 157

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 157
Study: 16542200

Group type: EXPERIMENTAL
Intervention: Tiotropium bromide 54 mcg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 40 mcg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 12669007

Group type: EXPERIMENTAL
Intervention: Low-Fat Dietary Modification Intervention
Number of subjects: 12030

Group type: EXPERIMENTAL
Intervention: Added fats
Number of subjects: 12030

Group type: EXPERIMENTAL
Intervention: Meats
Number of subjects: 12030

Group type: EXPERIMENTAL
Intervention: Desserts
Number of subjects: 12030

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 12030
Study: 10634377

Group type: EXPERIMENTAL
Intervention: Metformin (500 mg tid)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 9189734

Group type: EXPERIMENTAL
Intervention: Suberythematous ultraviolet (UV) radiation (groups II and III, 12 radiations in 4 weeks with two different spectra containing UV-B)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (no irradiation, group I)
Number of subjects: 24
Study: 1337458

Group type: EXPERIMENTAL
Intervention: Enalaprilat 2.5 mg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Enalaprilat
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 30926430

Group type: EXPERIMENTAL
Intervention: Polyethylene glycol plus simethicone (SIM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Polyethylene glycol
Number of subjects: 0
Study: 28647747

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy for Insomnia (MBCT-I)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Sleep Psycho-Education with Exercise Control (PEEC)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Both groups (MBCT-I and PEEC)
Number of subjects: 216
Study: 25560366

Group type: EXPERIMENTAL
Intervention: Power Point Presentation (PPT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Commercially available software (SW)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Traditional training (Control group - CF)
Number of subjects: 30
Study: 25106761

Group type: EXPERIMENTAL
Intervention: E‐ZES (Endeavour zotarolimus-eluting stent)
Number of subjects: 8791

Group type: COMPARATOR
Intervention: C‐SES (Cypher sirolimus-eluting stent)
Number of subjects: 8791

Group type: EXPERIMENTAL
Intervention: E‐ZES
Number of subjects: 8791

Group type: COMPARATOR
Intervention: C‐SES
Number of subjects: 8791
Study: 22296034

Group type: EXPERIMENTAL
Intervention: Repaglinide (3 mg day(-1) for 8 weeks)
Number of subjects: 368
Study: 19018143

Group type: EXPERIMENTAL
Intervention: Ezetimibe/simvastatin 10/40 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Doubling the dose of low-, medium-, and high-potency statins
Number of subjects: 0
Study: 18564433

Group type: EXPERIMENTAL
Intervention: Fibrin sealant (n = 16)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (n = 14)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fibrin sealant and Control
Number of subjects: 30
Study: 15939944

Group type: EXPERIMENTAL
Intervention: Capitated financing for mental health services
Number of subjects: 105

Group type: COMPARATOR
Intervention: Fee-for-service reimbursement
Number of subjects: 105
Study: 11788475

Group type: EXPERIMENTAL
Intervention: Albuterol
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27

Group type: COMPARATOR
Intervention: LNMMA
Number of subjects: 27
Study: 10394083

Group type: EXPERIMENTAL
Intervention: Fem7 (oestradiol matrix-type patch) at doses of 25, 50, 75 and 100 microg/24 h, applied once weekly
Number of subjects: 36
Study: 7653758

Group type: EXPERIMENTAL
Intervention: Hayek Oscillator with mean chamber pressure at -10 cmH2O
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Hayek Oscillator with mean chamber pressure at -20 cmH2O
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Hayek Oscillator with mean chamber pressure at 0 and -5 cmH2O
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Hayek Oscillator with varying peak-to-trough pressure span
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Increasing negative extrathoracic pressure
Number of subjects: 5
Study: 2202901

Group type: EXPERIMENTAL
Intervention: 50 mg of beta carotene per day
Number of subjects: 1805

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1805
Study: 7294222

Group type: EXPERIMENTAL
Intervention: Monitored group (urine specimens collected once a week)
Number of subjects: 431

Group type: COMPARATOR
Intervention: Unmonitored group (no urine specimens collected)
Number of subjects: 431
Study: 31504875

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided transversus abdominis plane block (TAPb)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Standard general anesthetic plus ultrasound-guided TAPb
Number of subjects: 96

Group type: COMPARATOR
Intervention: Standard general anesthetic (NO-TAP group)
Number of subjects: 96
Study: 31894028

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia with propofol
Number of subjects: 98

Group type: COMPARATOR
Intervention: Simple inhalation anesthesia with sevoflurane
Number of subjects: 98
Study: 29273067

Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg (IV-300 mg)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg (IV-150 mg)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg and 150 mg
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Secukinumab
Number of subjects: 226
Study: 26462848

Group type: EXPERIMENTAL
Intervention: Self-help with chat
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Self-help without chat
Number of subjects: 308

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 308
Study: 24040972

Group type: EXPERIMENTAL
Intervention: Congenitally blind subjects
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal-sighted subjects
Number of subjects: 0
Study: 21823343

Group type: EXPERIMENTAL
Intervention: Biofeedback (BF)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Electrical Stimulation (ES)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Biofeedback plus Electrical Stimulation (BF + ES)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 140
Study: 19716041

Group type: EXPERIMENTAL
Intervention: Neoral
Number of subjects: 16

Group type: COMPARATOR
Intervention: Cysporin
Number of subjects: 16
Study: 17668973

Group type: EXPERIMENTAL
Intervention: SRP plus 25% metronidazole gel
Number of subjects: 21

Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 21
Study: 15053885

Group type: EXPERIMENTAL
Intervention: Music group (n=99)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Non-music group (n=94)
Number of subjects: 193